Report cover image

Global Duck Medicine and Vaccines Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 193 Pages
SKU # APRC20361627

Description

Summary

According to APO Research, The global Duck Medicine and Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Duck Medicine and Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Duck Medicine and Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Duck Medicine and Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Duck Medicine and Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Duck Medicine and Vaccines include Zoetis, Yebio, Vaksindo, Ringpu Biology, QYH Biotech, Merial, Merck Animal Health, Harbin Veterinary Research Institute and FATRO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Duck Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Duck Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Duck Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Duck Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Duck Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Duck Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Duck Medicine and Vaccines Segment by Company

Zoetis
Yebio
Vaksindo
Ringpu Biology
QYH Biotech
Merial
Merck Animal Health
Harbin Veterinary Research Institute
FATRO
Elanco (Lohmann)
DHN
ChengDu Tecbond
CEVA
CAVAC
Duck Medicine and Vaccines Segment by Type

Medicine
Vaccines
Duck Medicine and Vaccines Segment by Application

Farm
Government
Duck Medicine and Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Duck Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Duck Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Duck Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Duck Medicine and Vaccines revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Duck Medicine and Vaccines Market by Type
1.2.1 Global Duck Medicine and Vaccines Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Medicine
1.2.3 Vaccines
1.3 Duck Medicine and Vaccines Market by Application
1.3.1 Global Duck Medicine and Vaccines Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Farm
1.3.3 Government
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Duck Medicine and Vaccines Market Dynamics
2.1 Duck Medicine and Vaccines Industry Trends
2.2 Duck Medicine and Vaccines Industry Drivers
2.3 Duck Medicine and Vaccines Industry Opportunities and Challenges
2.4 Duck Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
3.1 Global Duck Medicine and Vaccines Market Perspective (2020-2031)
3.2 Global Duck Medicine and Vaccines Growth Trends by Region
3.2.1 Global Duck Medicine and Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Duck Medicine and Vaccines Market Size by Region (2020-2025)
3.2.3 Global Duck Medicine and Vaccines Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Duck Medicine and Vaccines Revenue by Players
4.1.1 Global Duck Medicine and Vaccines Revenue by Players (2020-2025)
4.1.2 Global Duck Medicine and Vaccines Revenue Market Share by Players (2020-2025)
4.1.3 Global Duck Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Duck Medicine and Vaccines Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Duck Medicine and Vaccines Key Players Headquarters & Area Served
4.4 Global Duck Medicine and Vaccines Players, Product Type & Application
4.5 Global Duck Medicine and Vaccines Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Duck Medicine and Vaccines Market CR5 and HHI
4.6.3 2024 Duck Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Duck Medicine and Vaccines Market Size by Type
5.1 Global Duck Medicine and Vaccines Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Duck Medicine and Vaccines Revenue by Type (2020-2031)
5.3 Global Duck Medicine and Vaccines Revenue Market Share by Type (2020-2031)
6 Duck Medicine and Vaccines Market Size by Application
6.1 Global Duck Medicine and Vaccines Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Duck Medicine and Vaccines Revenue by Application (2020-2031)
6.3 Global Duck Medicine and Vaccines Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Comapny Information
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.1.4 Zoetis Duck Medicine and Vaccines Product Portfolio
7.1.5 Zoetis Recent Developments
7.2 Yebio
7.2.1 Yebio Comapny Information
7.2.2 Yebio Business Overview
7.2.3 Yebio Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.2.4 Yebio Duck Medicine and Vaccines Product Portfolio
7.2.5 Yebio Recent Developments
7.3 Vaksindo
7.3.1 Vaksindo Comapny Information
7.3.2 Vaksindo Business Overview
7.3.3 Vaksindo Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.3.4 Vaksindo Duck Medicine and Vaccines Product Portfolio
7.3.5 Vaksindo Recent Developments
7.4 Ringpu Biology
7.4.1 Ringpu Biology Comapny Information
7.4.2 Ringpu Biology Business Overview
7.4.3 Ringpu Biology Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.4.4 Ringpu Biology Duck Medicine and Vaccines Product Portfolio
7.4.5 Ringpu Biology Recent Developments
7.5 QYH Biotech
7.5.1 QYH Biotech Comapny Information
7.5.2 QYH Biotech Business Overview
7.5.3 QYH Biotech Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.5.4 QYH Biotech Duck Medicine and Vaccines Product Portfolio
7.5.5 QYH Biotech Recent Developments
7.6 Merial
7.6.1 Merial Comapny Information
7.6.2 Merial Business Overview
7.6.3 Merial Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.6.4 Merial Duck Medicine and Vaccines Product Portfolio
7.6.5 Merial Recent Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Comapny Information
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.7.4 Merck Animal Health Duck Medicine and Vaccines Product Portfolio
7.7.5 Merck Animal Health Recent Developments
7.8 Harbin Veterinary Research Institute
7.8.1 Harbin Veterinary Research Institute Comapny Information
7.8.2 Harbin Veterinary Research Institute Business Overview
7.8.3 Harbin Veterinary Research Institute Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.8.4 Harbin Veterinary Research Institute Duck Medicine and Vaccines Product Portfolio
7.8.5 Harbin Veterinary Research Institute Recent Developments
7.9 FATRO
7.9.1 FATRO Comapny Information
7.9.2 FATRO Business Overview
7.9.3 FATRO Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.9.4 FATRO Duck Medicine and Vaccines Product Portfolio
7.9.5 FATRO Recent Developments
7.10 Elanco (Lohmann)
7.10.1 Elanco (Lohmann) Comapny Information
7.10.2 Elanco (Lohmann) Business Overview
7.10.3 Elanco (Lohmann) Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.10.4 Elanco (Lohmann) Duck Medicine and Vaccines Product Portfolio
7.10.5 Elanco (Lohmann) Recent Developments
7.11 DHN
7.11.1 DHN Comapny Information
7.11.2 DHN Business Overview
7.11.3 DHN Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.11.4 DHN Duck Medicine and Vaccines Product Portfolio
7.11.5 DHN Recent Developments
7.12 ChengDu Tecbond
7.12.1 ChengDu Tecbond Comapny Information
7.12.2 ChengDu Tecbond Business Overview
7.12.3 ChengDu Tecbond Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.12.4 ChengDu Tecbond Duck Medicine and Vaccines Product Portfolio
7.12.5 ChengDu Tecbond Recent Developments
7.13 CEVA
7.13.1 CEVA Comapny Information
7.13.2 CEVA Business Overview
7.13.3 CEVA Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.13.4 CEVA Duck Medicine and Vaccines Product Portfolio
7.13.5 CEVA Recent Developments
7.14 CAVAC
7.14.1 CAVAC Comapny Information
7.14.2 CAVAC Business Overview
7.14.3 CAVAC Duck Medicine and Vaccines Revenue and Gross Margin (2020-2025)
7.14.4 CAVAC Duck Medicine and Vaccines Product Portfolio
7.14.5 CAVAC Recent Developments
8 North America
8.1 North America Duck Medicine and Vaccines Revenue (2020-2031)
8.2 North America Duck Medicine and Vaccines Revenue by Type (2020-2031)
8.2.1 North America Duck Medicine and Vaccines Revenue by Type (2020-2025)
8.2.2 North America Duck Medicine and Vaccines Revenue by Type (2026-2031)
8.3 North America Duck Medicine and Vaccines Revenue Share by Type (2020-2031)
8.4 North America Duck Medicine and Vaccines Revenue by Application (2020-2031)
8.4.1 North America Duck Medicine and Vaccines Revenue by Application (2020-2025)
8.4.2 North America Duck Medicine and Vaccines Revenue by Application (2026-2031)
8.5 North America Duck Medicine and Vaccines Revenue Share by Application (2020-2031)
8.6 North America Duck Medicine and Vaccines Revenue by Country
8.6.1 North America Duck Medicine and Vaccines Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Duck Medicine and Vaccines Revenue by Country (2020-2025)
8.6.3 North America Duck Medicine and Vaccines Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Duck Medicine and Vaccines Revenue (2020-2031)
9.2 Europe Duck Medicine and Vaccines Revenue by Type (2020-2031)
9.2.1 Europe Duck Medicine and Vaccines Revenue by Type (2020-2025)
9.2.2 Europe Duck Medicine and Vaccines Revenue by Type (2026-2031)
9.3 Europe Duck Medicine and Vaccines Revenue Share by Type (2020-2031)
9.4 Europe Duck Medicine and Vaccines Revenue by Application (2020-2031)
9.4.1 Europe Duck Medicine and Vaccines Revenue by Application (2020-2025)
9.4.2 Europe Duck Medicine and Vaccines Revenue by Application (2026-2031)
9.5 Europe Duck Medicine and Vaccines Revenue Share by Application (2020-2031)
9.6 Europe Duck Medicine and Vaccines Revenue by Country
9.6.1 Europe Duck Medicine and Vaccines Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Duck Medicine and Vaccines Revenue by Country (2020-2025)
9.6.3 Europe Duck Medicine and Vaccines Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Duck Medicine and Vaccines Revenue (2020-2031)
10.2 China Duck Medicine and Vaccines Revenue by Type (2020-2031)
10.2.1 China Duck Medicine and Vaccines Revenue by Type (2020-2025)
10.2.2 China Duck Medicine and Vaccines Revenue by Type (2026-2031)
10.3 China Duck Medicine and Vaccines Revenue Share by Type (2020-2031)
10.4 China Duck Medicine and Vaccines Revenue by Application (2020-2031)
10.4.1 China Duck Medicine and Vaccines Revenue by Application (2020-2025)
10.4.2 China Duck Medicine and Vaccines Revenue by Application (2026-2031)
10.5 China Duck Medicine and Vaccines Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Duck Medicine and Vaccines Revenue (2020-2031)
11.2 Asia Duck Medicine and Vaccines Revenue by Type (2020-2031)
11.2.1 Asia Duck Medicine and Vaccines Revenue by Type (2020-2025)
11.2.2 Asia Duck Medicine and Vaccines Revenue by Type (2026-2031)
11.3 Asia Duck Medicine and Vaccines Revenue Share by Type (2020-2031)
11.4 Asia Duck Medicine and Vaccines Revenue by Application (2020-2031)
11.4.1 Asia Duck Medicine and Vaccines Revenue by Application (2020-2025)
11.4.2 Asia Duck Medicine and Vaccines Revenue by Application (2026-2031)
11.5 Asia Duck Medicine and Vaccines Revenue Share by Application (2020-2031)
11.6 Asia Duck Medicine and Vaccines Revenue by Country
11.6.1 Asia Duck Medicine and Vaccines Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Duck Medicine and Vaccines Revenue by Country (2020-2025)
11.6.3 Asia Duck Medicine and Vaccines Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Duck Medicine and Vaccines Revenue (2020-2031)
12.2 SAMEA Duck Medicine and Vaccines Revenue by Type (2020-2031)
12.2.1 SAMEA Duck Medicine and Vaccines Revenue by Type (2020-2025)
12.2.2 SAMEA Duck Medicine and Vaccines Revenue by Type (2026-2031)
12.3 SAMEA Duck Medicine and Vaccines Revenue Share by Type (2020-2031)
12.4 SAMEA Duck Medicine and Vaccines Revenue by Application (2020-2031)
12.4.1 SAMEA Duck Medicine and Vaccines Revenue by Application (2020-2025)
12.4.2 SAMEA Duck Medicine and Vaccines Revenue by Application (2026-2031)
12.5 SAMEA Duck Medicine and Vaccines Revenue Share by Application (2020-2031)
12.6 SAMEA Duck Medicine and Vaccines Revenue by Country
12.6.1 SAMEA Duck Medicine and Vaccines Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Duck Medicine and Vaccines Revenue by Country (2020-2025)
12.6.3 SAMEA Duck Medicine and Vaccines Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.